ID: ALA4574783

Max Phase: Preclinical

Molecular Formula: C10H12N4S

Molecular Weight: 220.30

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)Sc1nnnn1-c1ccccc1

Standard InChI:  InChI=1S/C10H12N4S/c1-8(2)15-10-11-12-13-14(10)9-6-4-3-5-7-9/h3-8H,1-2H3

Standard InChI Key:  SRXNAOIEUJQDHS-UHFFFAOYSA-N

Associated Targets(Human)

PDE6D Tclin Phosphodiesterase 6D (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 220.30Molecular Weight (Monoisotopic): 220.0783AlogP: 2.16#Rotatable Bonds: 3
Polar Surface Area: 43.60Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.89CX LogD: 2.89
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.74Np Likeness Score: -2.98

References

1. Chen D, Chen Y, Lian F, Chen L, Li Y, Cao D, Wang X, Chen L, Li J, Meng T, Huang M, Geng M, Shen J, Zhang N, Xiong B..  (2019)  Fragment-based drug discovery of triazole inhibitors to block PDEδ-RAS protein-protein interaction.,  163  [PMID:30562696] [10.1016/j.ejmech.2018.12.018]

Source